Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the Netherlands / NCT06920550
Active, not recruiting Observational

A Growth Artificial Intelligence Algorithm for leNgth and Weight Study

NCT06920550 · tracked via the Priya Life Science Netherlands tracker
Sponsor
Nutricia Research
Phase
Observational
Started
2024-12-20
Last updated
2026-05-22

Condition(s) studied

LengthWeight

Study summary

This is a data collection and machine learning accuracy testing project that aims to a) collect training data to enhance, by machine learning, an artificial intelligence (AI) algorithm for measuring length in infants and young children and b) test the accuracy of the AI algorithm by comparing the AI predicted length with the gold standard measured length. Images and videos will be collected by care givers and healthcare professionals, together with physical length measurements. These data will be used to train the AI algorithm and to explore potential improvements. Other data to be collected is user experience feedback.

Eligibility

Sex
ALL
Min age
0 Months
Max age
24 Months
Healthy volunteers
Accepted
Inclusion Criteria: 1. Infants/young children aged 0 to 24 months old at enrolment; 2. Caregiver(s) have access to the internet and a smartphone or tablet to complete questionnaires, take images and videos, and upload these; 3. Written informed consent from one or both caregivers (according to local laws) or legally acceptable representative(s) aged ≥ 18 years at enrolment. Exclusion Criteria: 1. Children unable to undergo length or weight measurements when applying standardized techniques recommended by the WHO (e.g. infants/children with structural abnormalities of the lower limbs or orthopaedic conditions (e.g. club foot, hip dysplasia)). 2. Research staff's uncertainty about the caregiver's ability or willingness to complete the study according to the instructions

Primary outcome measure(s)

  • Accuracy length AI — Date of enrolment, at baseline
    Accuracy of the Length AI vs length gold standard (WHO methodology with length board in cm) assessed using several different parameters: the bias (cm), agreement and reliability measures, mean absolute error (cm), mean absolute percentage error (%), percentiles of the absolute error (cm), and root mean square error (cm).
  • Accuracy caregiver length — Date of enrolment, at baseline
    Accuracy of the caregiver measured length (own preferred methodology in cm) vs gold standard measured length (WHO methodology with length board in cm), assessed by same parameters as mentioned in the first primary outcome measure.
  • Accuracy caregiver vs AI length — Date of enrolment, at baseline
    Accuracy of the caregiver measurements (self preferred methodology in cm) vs Length AI by same parameters as mentioned in the first primary outcome measure.

Trial sites (4)

FacilityCityRegionStatus
Franciscus Gasthuis Rotterdam Netherlands
Ginemedica Wroclaw Poland
Hospital Universitario Puerta del Mar Cadiz Spain
Hospital Universitario de Jerez dela Frontera Jerez de la Frontera Spain

More Nutricia Research trials in the Netherlands

A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk Recruiting
A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06920550 on ClinicalTrials.gov ↗ ← All trials in the Netherlands